UPADACITINIB IMPROVES STEROID-FREE CLINICAL AND ENDOSCOPIC ENDPOINTS IN PATIENTS WITH CROHN'S DISEASE: DATA FROM THE CELEST STUDY

被引：0
|
作者：
Panaccione, Remo
Atreya, Raja
Ferrante, Marc
Dubinsky, Marla
Sands, Bruce E.
Abreu, Maria T.
Cataldi, Fabio
Enejosa, Jeffrey V.
Zhou, Qian
Huang, Bidan
Lacerda, Ana P.
Pangan, Aileen L.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1758
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study
    Panaccione, R.
    Atreya, R.
    Ferrante, M.
    Dubinsky, M. C.
    Sands, B. E.
    Abreu, M. T.
    Cataldi, F.
    Enejosa, J. V.
    Zhou, Q.
    Huang, B.
    Lacerda, A. P.
    Pangan, A. L.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S412 - S413
  • [2] IMPACT OF UPADACITINIB ON THE GENERAL CLINICAL CONDITION OF PATIENTS WITH CROHN'S DISEASE (CD): DATA FROM THE RANDOMISED CELEST STUDY
    Loftus, Edward V.
    Rubin, David T.
    Panes, Julian
    Pugatch, David
    Zhou, Wen
    Goteti, Venkata Sasikiran
    Lacerda, Ana P.
    Travis, Simon P.
    GASTROENTEROLOGY, 2019, 156 (06) : S1095 - S1095
  • [3] Impact of upadacitinib on the general clinical condition of patients with Crohn's disease (CD): data from the randomised CELEST study
    Loftus, E. V., Jr.
    Rubin, D. T.
    Panes, J.
    Pugatch, D.
    Zhou, W.
    Goteti, S.
    Lacerda, A.
    Travis, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S257 - S257
  • [4] DOSE ESCALATION OF UPADACITINIB IN CROHN'S DISEASE PATIENTS WITH INADEQUATE RESPONSE: DATA FROM THE RANDOMISED CELEST STUDY
    Sandborn, William J.
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Louis, Edouard
    Greenbloom, Susan
    Zhou, Wen
    Zhou, Qian
    Liu, Jianzhong
    Lacerda, Ana P.
    GASTROENTEROLOGY, 2020, 158 (06) : S1187 - S1187
  • [5] CORRELATION OF ENDOSCOPIC AND CLINICAL ENDPOINTS DURING INDUCTION THERAPY IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: ANALYSIS FROM CELEST STUDY
    Sandborn, William J.
    Feagan, Brian G.
    Lewis, James
    Danese, Silvio
    Reinisch, Walter
    Rubin, David T.
    Zhou, Wen
    Cataldi, Fabio
    Zhou, Qian
    Goteti, Venkata Sasikiran
    Lacerda, Ana P.
    GASTROENTEROLOGY, 2018, 154 (06) : S590 - S590
  • [6] Dose escalation of upadacitinib in Crohn's disease patients with an inadequate response: Data from the randomised CELEST study
    Sandborn, W.
    Panes, J.
    Peyrin-Biroulet, L.
    Louis, E.
    Greenbloom, S.
    Zhou, W.
    Zhou, Q.
    Liu, J.
    Lacerda, A. P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S117 - S118
  • [7] Correlation of endoscopic and clinical endpoints during induction therapy in patients with moderate-to-severe Crohn's disease: Analysis from CELEST study
    Sandborn, W. J.
    Feagan, B.
    Lewis, J. D.
    Danese, S.
    Reinisch, W.
    Rubin, D. T.
    Zhou, W.
    Cataldi, F.
    Zhou, Q.
    Goteti, S.
    Lacerda, A. P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S375 - S376
  • [8] EFFECT OF UPADACITINIB ON EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: DATA FROM THE CELEST STUDY
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Louis, Edouard
    Higgins, Peter D.
    Dubinsky, Marla
    Cataldi, Fabio
    Zhou, Qian
    Lee, Wan-Ju
    Kligys, Kristina
    GASTROENTEROLOGY, 2019, 156 (06) : S856 - S856
  • [9] Effect of upadacitinib on extra-intestinal manifestations in patients with moderate to severe Crohn's disease: data from the CELEST study
    Peyrin-Biroulet, L.
    Danese, S.
    Louis, E.
    Higgins, P. D. R.
    Dubinsky, M.
    Cataldi, F.
    Zhou, Q.
    Lee, W. -J.
    Kligys, K.
    Lacerda, A. P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S57 - S57
  • [10] Sustained steroid-free clinical remission in patients with moderate to severe Crohn's disease treated with adalimumab
    Hanauer, Stephen B.
    Kaam, M. A.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S460 - S460
12345